I. Stoilov

发表

The Third Genetic Locus (GLC3C) for Primary Congenital Glaucoma (PCG) Maps to Chromosome 14q24.3

M. Sarfarazi, I. Stoilov, 2002 .

Molecular genetics of primary congenital glaucoma in Brazil.

V. P. Costa, M. Sarfarazi, J. P. Vasconcellos, 2002, Investigative ophthalmology & visual science.

Ultra-Response to Ranibizumab: Improvement by 4 or More Steps in Diabetic Retinopathy Severity in Diabetic Retinopathy Clinical Research Network Protocol S

A. Ho, S. Garg, M. Klufas, 2021 .

Age-related Macular Degeneration patient deep phenotyping and whole genome sequencing analysis identifies coding variants linking small low-luminance visual deficit to fat storage defects

Simon S. Gao, B. Yaspan, A. Wuster, 2022, bioRxiv.

The Value of Prior Response to Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration: A HARBOR Subanalysis.

R. Khurana, Lauren Hill, Louis K. Chang, 2019, Ophthalmology. Retina.

Changes in Treatment-Naive Pigment Epithelial Detachments Associated With the Initial Anti–Vascular Endothelial Growth Factor Injection

M. Javaheri, Lauren Hill, I. Stoilov, 2020, JAMA ophthalmology.

Enhanced expression of CYP1B1 in Escherichia coli.

J. Schenkman, M. Sarfarazi, I. Jansson, 2000, Toxicology.

Genomic structure of HOXD13 gene: a nine polyalanine duplication causes synpolydactyly in two unrelated families.

M. Sarfarazi, A. Akarsu, B. Şayli, 1996, Human molecular genetics.

Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1.

J. Schenkman, D. Choudhary, M. Sarfarazi, 2004, Drug metabolism and disposition: the biological fate of chemicals.

Expression of cytochrome P 450 1 b 1 ( Cyp 1 b 1 ) during early murine development

J. Schenkman, T. Rezaie, M. Sarfarazi, 2004 .

Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1.

A. Child, G. Brice, M. Sarfarazi, 1998, American journal of human genetics.

Altered leukotriene B4 metabolism in CYP4F18-deficient mice does not impact inflammation following renal ischemia.

F. Preffer, D. Dombkowski, D. Choudhary, 2014, Biochimica et biophysica acta.

Genotype and phenotype correlations in congenital glaucoma: CYP1B1 mutations, goniodysgenesis, and clinical characteristics.

M. Sarfarazi, J. Alvarado, D. Hollander, 2006, American journal of ophthalmology.

Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma

V. Ferák, M. Sarfarazi, M. Plášilová, 1999, Journal of medical genetics.

Screening for point mutations in the LDL receptor gene in Bulgarian patients with severe hypercholesterolemia

A. Horvath, V. Mihaylov, I. Paskaleva, 2004, Journal of Human Genetics.

Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21.

M. Sarfarazi, A. Akarsu, I. Stoilov, 1997, Human molecular genetics.

Drugs for macular degeneration.

Roman G. Rubio, A. Fung, I. Stoilov, 2014, JAMA.

Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues.

J. Schenkman, D. Choudhary, M. Sarfarazi, 2003, Archives of biochemistry and biophysics.

Molecular genetics of primary congenital glaucoma

M. Sarfarazi, I. Stoilov, 2000, Eye.

Genotype and phenotype correlations in congenital glaucoma.

M. Sarfarazi, J. Alvarado, D. Hollander, 2006, Transactions of the American Ophthalmological Society.

Roles of Cytochrome P450 in Development

J. Schenkman, M. Sarfarazi, I. Stoilov,, 2001, Drug metabolism and drug interactions.

Genetics and biochemistry of primary congenital glaucoma.

J. Schenkman, M. Sarfarazi, I. Stoilov, 2003, Ophthalmology clinics of North America.

A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia.

P. Tsipouras, M. Kilpatrick, I. Stoilov, 1995, American journal of medical genetics.

The gene for achondroplasia maps to the telomeric region of chromosome 4p

J. Gusella, S. Slaugenhaupt, M. Velinov, 1994, Nature Genetics.

Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism.

J. Schenkman, M. Sarfarazi, I. Jansson, 2001, Pharmacogenetics.

Cytochrome P450s: coupling development and environment.

I. Stoilov, 2001, Trends in genetics : TIG.

Possible genetic heterogeneity in hypochondroplasia.

P. Tsipouras, T. Costa, M. Kilpatrick, 1995, Journal of medical genetics.

Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues.

J. Schenkman, D. Choudhary, M. Sarfarazi, 2005, Archives of biochemistry and biophysics.

Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy

A. Maunz, M. Zarbin, M. Gliem, 2021, British Journal of Ophthalmology.

Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision

H. Shapiro, R. Frenkel, I. Stoilov, 2015, British Journal of Ophthalmology.

The Impact of Systemic Factors on Clinical Response to Ranibizumab for Diabetic Macular Edema.

Rishi P. Singh, J. Ehlers, Lauren Hill, 2016, Ophthalmology.

Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy

C. Wykoff, F. Lum, Q. Nguyen, 2021, Diabetes Care.

Expression of cytochrome P4501b1 (Cyp1b1) during early murine development.

J. Schenkman, T. Rezaie, M. Sarfarazi, 2004, Molecular Vision.

Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials.

C. Regillo, M. Elman, C. Wykoff, 2016, Ophthalmology.

Rare CIDEC coding variants enriched in age-related macular degeneration patients with small low-luminance deficit cause lipid droplet and fat storage defects

Simon S. Gao, B. Yaspan, A. Wuster, 2023, PloS one.

Course of Diabetic Retinopathy in Untreated Fellow Eyes in RIDE and RISE: A Post Hoc Analysis.

S. Bakri, I. Stoilov, Mila Malhotra, 2022, Ophthalmic surgery, lasers & imaging retina.

Ultra-Response to Ranibizumab: Improvement by 4 or More Steps in Diabetic Retinopathy Severity in DRCR.net Protocol S.

A. Ho, S. Garg, M. Klufas, 2020, Ophthalmology. Retina.

Advances in the treatment of diabetic retinopathy.

Rishi P. Singh, M. Elman, A. Fung, 2019, Journal of diabetes and its complications.

Timing of Peak Vision Gains in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab.

R. Khurana, Louis K. Chang, I. Stoilov, 2020, Ophthalmology. Retina.

Simulating an Anti-Vascular Endothelial Growth Factor Switch in Neovascular Age-Related Macular Degeneration: A HARBOR Subanalysis.

M. Zarbin, Lauren Hill, I. Stoilov, 2019, Ophthalmology.

The cytochromes P450 (CYP) response to allergic inflammation of the lung.

R. Thrall, Anupinder Kaur, L. Guernsey, 2006, Archives of biochemistry and biophysics.

Effect of less aggressive treatment on diabetic retinopathy severity scale scores: analyses of the RIDE and RISE open-label extension

R. Goldberg, Lauren Hill, I. Stoilov, 2022, BMJ Open Ophthalmology.

Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.

J. Monés, C. Baumal, I. Stoilov, 2024, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie.

Efficacy of Faricimab vs Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase 3 YOSEMITE/RHINE Trials

I. Stoilov, David Tabano, M. Zarbin, 2024, Ophthalmology.

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME

K. Csaky, I. Stoilov, Peter D Westenskow, 2023, Translational vision science & technology.